HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CVSA

Covista Inc. (NYSE)

Consumer Defensive — Education & Training Services

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

Strong Buy 1.3 / 5 4 analysts
$128.23
+$3.57 (+2.86%)
Target: $156.25 (21.9%)
Sign in to add CVSA to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$4.36B
P/E Ratio (TTM)18.67
Forward P/E14.43
EPS (TTM)$6.87
Dividend Yield-
Profit Margin12.26%
Revenue Growth4.50%
ROE17.85%
Debt/Equity53.98
Recommendation Strong Buy 1.3
Analyst Target$156.25
Analysts4
Indexes NYSE

Technical Indicators

RSI (14)47.1
Beta0.62
SMA 20-
SMA 40-
52-Week High$156.26
52-Week Low$86.97
50-Day Avg$121.93
200-Day Avg$115.85
Avg Volume312.9K
Volume318.9K

Performance Analysis

BULLISH

CVSA shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 60% of its 52-week range.
~ RSI at 47.1 is in neutral territory.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 4.5% year-over-year.
+ Wall Street consensus is "Strong Buy" from 4 analysts.
+ Average analyst target of $156.25 implies 21.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:05 UTC

Back to Screener Export Report